secwatch.observer — SEC 8-K summary
======================================

Issuer:     bioAffinity Technologies, Inc. (BIAF)
CIK:        0001712762
Form:       8-K
Filed at:   2026-02-04T23:59:59+00:00
Accession:  0001493152-26-005109
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

bioAffinity Technologies sets 2026 Annual Meeting for April 30; proposal deadline Feb 14
--------------------------------------------------------------------------------

- Annual Meeting scheduled for April 30, 2026 at company's principal executive offices in San Antonio, TX.
- Special Meeting of Stockholders (Dec 19, 2025) adjourned without business due to lack of quorum; proposals will be included in Annual Meeting.
- Stockholder proposals or director nominations must be received by Feb 14, 2026, ten days after this announcement.
- Details of proposals and proxy statement to be filed with SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226005109/0001493152-26-005109-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1712762/000149315226005109/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-005109

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer